MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Central and Peripheral neurological manifestations of COVID-19 in a cohort of patients with Parkinson’s disease.

A. Vaish, B. Tyson, S. Ray (Redmond, USA)

Meeting: MDS Virtual Congress 2021

Abstract Number: 657

Keywords: Cognitive dysfunction, Deep brain stimulation (DBS), Parkinson’s

Category: Parkinson's Disease and Lewy Body Dementia

Objective: To describe central and peripheral neurological manifestations in patients with COVID-19 and Parkinson’s disease.

Background: COVID-19 is associated with central and peripheral neurological manifestations. In patients with preexisting neurological conditions such as Parkinson’s disease (PD), identifying new neurological manifestations can be difficult, particularly when COVID-19 symptoms such as decreased smell and taste represent baseline PD symptoms.

Method: We reviewed central and peripheral neurological manifestations of COVID-19 in 12 consecutive patients with PD who presented to a suburban hospital and affiliated clinics in Washington State, USA.

Results: The median age was 72.5 years, of which 58% were male and 83% were Caucasian. Central neurological manifestations of COVID-19 were noted in 58% of patients.  New onset or worsening lightheadedness was present in 17% of patients. Four of 12 patients (33%) presented with metabolic encephalopathy, of which three had PD dementia and one died. Four of 12 patients (33%) presented with worsening balance, of which one had bilateral deep brain stimulators. Three of 12 patients (25%)
had no neurological manifestations with one of these patients receiving monoclonal antibody infusion as FDA emergency use authorization. Only one patient had peripheral neurological manifestations of neuropathic pain and myalgia. No patients reported new onset of loss of taste or smell.

Conclusion: The majority of patients with PD patients reported central neurological manifestations of lightheadedness, metabolic encephalopathy, and/or worsening balance. Only one reported peripheral neurological manifestations in this cohort.  Loss of smell and taste, which are common COVID-19 symptoms, were not reported in our sample, likely due to baseline loss of smell and taste being common baseline symptoms in this patient population. Metabolic encephalopathy was a common presentation of COVID-19 in those with PD dementia and associated with high mortality.

To cite this abstract in AMA style:

A. Vaish, B. Tyson, S. Ray. Central and Peripheral neurological manifestations of COVID-19 in a cohort of patients with Parkinson’s disease. [abstract]. Mov Disord. 2021; 36 (suppl 1). https://www.mdsabstracts.org/abstract/central-and-peripheral-neurological-manifestations-of-covid-19-in-a-cohort-of-patients-with-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2021

MDS Abstracts - https://www.mdsabstracts.org/abstract/central-and-peripheral-neurological-manifestations-of-covid-19-in-a-cohort-of-patients-with-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley